Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe

@article{Hawser2010ActivityOT,
  title={Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe},
  author={Stephen P Hawser},
  journal={European Journal of Clinical Microbiology & Infectious Diseases},
  year={2010},
  volume={29},
  pages={1011-1013}
}
A total of 206 clinical isolates of Finegoldia magna were collected during the period 2007–2009 from six European countries. The majority of isolates were from body fluids (n = 83; 40.3%) or wounds (n = 82; 39.8%). All isolates were susceptible to tigecycline, meropenem, metronidazole and piperacillin / tazobactam, though susceptibility to penicillin (86.4–87.4%) and clindamycin (78.2–93.3%) were more variable.